Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hiroko Endo

Showing results (51-60 of 57) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 57 results.
Plos One|November 17, 2015
Immuno-PET Imaging of HER3 in a Model in which HER3 Signaling Plays a Critical RoleQinghua Yuan, Takako Furukawa, Takahiro Tashiro, et al.
Blood Cancer Journal|May 7, 2026
Docirbrutinib is a pan-mutant BTK inhibitor and inhibits B-cell receptor signaling in chronic lymphocytic leukemia cells in preclinical and early clinical investigationsNatalia Timofeeva, Breana Herrera, Hitomi Fujiwara, et al.
Regulatory Toxicology and Pharmacology : RTP|February 18, 2016
CSAHi study: Validation of multi-electrode array systems (MEA60/2100) for prediction of drug-induced proarrhythmia using human iPS cell-derived cardiomyocytes -assessment of inter-facility and cells lot-to-lot-variabilityYumiko Nozaki, Yayoi Honda, Hitoshi Watanabe, et al.
Journal of Human Genetics|February 10, 2004
Linkage and association of childhood asthma with the chromosome 12 genesChenchen Shao, Yoichi Suzuki, Fumiaki Kamada, et al.
Regulatory Toxicology and Pharmacology : RTP|June 22, 2017
CSAHi study-2: Validation of multi-electrode array systems (MEA60/2100) for prediction of drug-induced proarrhythmia using human iPS cell-derived cardiomyocytes: Assessment of reference compounds and comparison with non-clinical studies and clinical informationYumiko Nozaki, Yayoi Honda, Hitoshi Watanabe, et al.
International Archives of Allergy and Immunology|July 24, 2007
The GSTP1 gene is a susceptibility gene for childhood asthma and the GSTM1 gene is a modifier of the GSTP1 geneFumiaki Kamada, Yoichi Mashimo, Hiroki Inoue, et al.
Nature Communications|May 27, 2017
The distinct metabolic phenotype of lung squamous cell carcinoma defines selective vulnerability to glycolytic inhibitionJustin Goodwin, Michael L Neugent, Shin Yup Lee, et al.
Pageof 6

Showing results (51-60 of 57) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 57 results.
Plos One|November 17, 2015
Immuno-PET Imaging of HER3 in a Model in which HER3 Signaling Plays a Critical RoleQinghua Yuan, Takako Furukawa, Takahiro Tashiro, et al.
Blood Cancer Journal|May 7, 2026
Docirbrutinib is a pan-mutant BTK inhibitor and inhibits B-cell receptor signaling in chronic lymphocytic leukemia cells in preclinical and early clinical investigationsNatalia Timofeeva, Breana Herrera, Hitomi Fujiwara, et al.
Regulatory Toxicology and Pharmacology : RTP|February 18, 2016
CSAHi study: Validation of multi-electrode array systems (MEA60/2100) for prediction of drug-induced proarrhythmia using human iPS cell-derived cardiomyocytes -assessment of inter-facility and cells lot-to-lot-variabilityYumiko Nozaki, Yayoi Honda, Hitoshi Watanabe, et al.
Journal of Human Genetics|February 10, 2004
Linkage and association of childhood asthma with the chromosome 12 genesChenchen Shao, Yoichi Suzuki, Fumiaki Kamada, et al.
Regulatory Toxicology and Pharmacology : RTP|June 22, 2017
CSAHi study-2: Validation of multi-electrode array systems (MEA60/2100) for prediction of drug-induced proarrhythmia using human iPS cell-derived cardiomyocytes: Assessment of reference compounds and comparison with non-clinical studies and clinical informationYumiko Nozaki, Yayoi Honda, Hitoshi Watanabe, et al.
International Archives of Allergy and Immunology|July 24, 2007
The GSTP1 gene is a susceptibility gene for childhood asthma and the GSTM1 gene is a modifier of the GSTP1 geneFumiaki Kamada, Yoichi Mashimo, Hiroki Inoue, et al.
Nature Communications|May 27, 2017
The distinct metabolic phenotype of lung squamous cell carcinoma defines selective vulnerability to glycolytic inhibitionJustin Goodwin, Michael L Neugent, Shin Yup Lee, et al.
Pageof 6